Home/Filings/4/0001209191-20-000816
4//SEC Filing

Wade M. Andrew 4

Accession 0001209191-20-000816

CIK 0001323885other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:09 PM ET

Size

5.0 KB

Accession

0001209191-20-000816

Insider Transaction Report

Form 4
Period: 2019-12-31
Wade M. Andrew
Vice President, Finance
Transactions
  • Award

    Common Stock

    2019-12-31$25.99/sh+405$10,526145,120 total
Footnotes (2)
  • [F1]Shares acquired pursuant to the AtriCure, Inc. 2018 Employee Stock Purchase Plan for the period ended December 31, 2019.
  • [F2]In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on July 1, 2019, which was the first trading day of the applicable offering period. The closing price on July 1, 2019 was $30.58.

Issuer

AtriCure, Inc.

CIK 0001323885

Entity typeother

Related Parties

1
  • filerCIK 0001560591

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:09 PM ET
Size
5.0 KB